Congenital adrenal hyperplasia and P450 oxidoreductase deficiency
- 18 December 2006
- journal article
- review article
- Published by Wiley in Clinical Endocrinology
- Vol. 66 (2) , 162-172
Abstract
Summary: Congenital adrenal hyperplasia (CAH) comprises a group of autosomal recessive disorders, which are usually due to inactivating mutations in single enzymes involved in adrenal steroid biosynthesis. The characteristics of the biochemical and clinical phenotype depend on the specific enzymatic defect. In 21‐hydroxylase and 11β‐hydroxylase deficiency only adrenal steroidogenesis is affected, whereas a defect in 3β‐hydroxysteroid dehydrogenase or 17α‐hydroxylase also involves gonadal steroid biosynthesis. Recently, mutations in the electron donor enzyme P450 oxidoreductase were identified as the cause of CAH with apparent combined 17α‐hydroxylase and 21‐hydroxylase deficiency, thereby illustrating the impact of redox regulation enzymes on steroidogenesis. P450 oxidoreductase deficiency (ORD) has a complex phenotype including two unique features not observed in any other CAH variant, skeletal malformations and severe genital ambiguity in both sexes. Despite invariably low circulating androgens, females with ORD may present with virilized genitalia and mothers may suffer from virilization during pregnancy. This apparently contradictory finding may be explained by the existence of an alternative pathway in human androgen biosynthesis, with important implications for physiology and pathophysiology. This review discusses the biochemical and clinical presentation and the genetic and functional basis of the currently known CAH variants, with a specific focus on ORD.Keywords
This publication has 94 references indexed in Scilit:
- Congenital adrenal hyperplasia in adults: a review of medical, surgical and psychological issuesClinical Endocrinology, 2005
- Abnormal steroidogenesis in three patients with Antley–Bixler syndrome: Apparent decreased activity of 17α‐hydroxylase, 17,20‐lyase and 21‐hydroxylasePediatrics International, 2004
- Consensus Statement on 21-Hydroxylase Deficiency from The European Society for Paediatric Endocrinology and The Lawson Wilkins Pediatric Endocrine SocietyHormone Research in Paediatrics, 2002
- Induction of endometrial cycles and ovulation in a woman with combined 17α-hydroxylase/17,20-lyase deficiency due to compound heterozygous mutations on the P45017α geneFertility and Sterility, 2000
- Novel CYP11B1 Mutations in Congenital Adrenal Hyperplasia due to Steroid 11 -Hydroxylase DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 1998
- Mutation of cytochrome P-45017 alpha gene (CYP17) in a Japanese patient previously reported as having glucocorticoid-responsive hyperaldosteronism: with a review of Japanese patients with mutations of CYP17The Journal of Clinical Endocrinology & Metabolism, 1996
- CYP11B1 mutations causing congenital adrenal hyperplasia due to 11 beta- hydroxylase deficiencyThe Journal of Clinical Endocrinology & Metabolism, 1996
- Classic Steroid 11β-Hydroxylase Deficiency Caused by a C→G Transversion in Exon 7 of CYP11B1Biochemical and Biophysical Research Communications, 1995
- A nonsense mutation (TGG [Trp116]-->TAG [Stop]) in CYP11B1 causes steroid 11 beta-hydroxylase deficiencyThe Journal of Clinical Endocrinology & Metabolism, 1993
- Male Pseudohermaphroditism Due to Multiple Defects in Steroid-Biosynthetic Microsomal Mixed-Function OxidasesNew England Journal of Medicine, 1985